Research Reports

Every report we've published, newest first.

MGRX

MGRX: The $73 Million Hail Mary - Why This Lawsuit Play Doubled Overnight

Mar 23, 2026

MGRX popped 116% on a $73M lawsuit against its former tech partner, but the damages sought are 11x the company's market cap—classic small-cap narrative engineering.

Read →
AGRZ

AGRZ: Vertical Farm Play Catches Fertilizer Wave at Critical Technical Crossroads

Mar 20, 2026

Agroz bounced 153% last Thursday on the Strait of Hormuz crisis, then gave back 27% Friday. Now trading at key support with a Nasdaq compliance deadline looming.

Read →
ANNA

ANNA Surges 50% on Iran War Energy Crisis But Major Insider Sells Signal Caution

Mar 20, 2026

ANNA explodes 50% as Iran war drives energy crisis, but massive insider selling from controlling shareholders just before the rally raises serious red flags about sustainability.

Read →
AZTR

AZTR: Private Placement Lifeline or Dilution Trap?

Mar 20, 2026

AZTR rockets 92% on desperate biotech financing that could deliver either runway extension or massive dilution trap for retail traders.

Read →
WETO

WETO's Phantom Surge: What the 57% Pop on Corporate Rebrand News Doesn't Tell You

Mar 19, 2026

Wetour Robotics' 57% surge Wednesday masks deeper questions about dilution risk and a pivot from struggling travel tech to unproven AI infrastructure.

Read →
SER

SER Private Placement Mechanics: How Serina's $30M Raise Shows the New Biotech Financing Playbook

Mar 19, 2026

Serina Therapeutics surged 76% on a $30M private placement deal, but the real story is in the warrant mechanics and potential $63M dilution structure.

Read →
LNKS

LNKS Pops 24% Pre-Market on No News After Massive Dilution Filing

Mar 19, 2026

Linkers Industries surges pre-market despite filing to dump up to 405 million shares into the market just days ago, raising questions about what traders aren't seeing.

Read →
CHNR

CHNR Explodes 71% Pre-Market on AI Pivot, But This Mining Stock's Real Test Lies Ahead

Mar 19, 2026

China Natural Resources rockets on HooRii Technology acquisition announcement, but traders should watch the $37-40 million dilution event closely — the Physical AI story might be secondary to the balance sheet math.

Read →
EVTV

EVTV: The Electric Vehicle Stock That Broke Bad and Went Full AI — Tape Read

Mar 18, 2026

EVTV's 46% rip on 8.3M volume tells the story of a desperation pivot gone right, but dilution demons still lurk in the shadows.

Read →
ARTL

ARTL Pops 33% on Glaucoma Study Deal, But Don't Ignore the Warning Signs

Mar 18, 2026

ARTL exploded 33% on glaucoma study news with 72x float volume, but the cash burn and dilution risks make this more squeeze than substance.

Read →
VNRX

VNRX Pops 39% on "World-First" Liquid Biopsy Breakthrough Amid Delisting Risks

Mar 18, 2026

VNRX explodes 39% on breakthrough liquid biopsy claims, but massive volume and delisting pressures create a complex risk-reward setup.

Read →
LBGJ

LBGJ: The Anatomy of a 138% Pre-Market Pump — And Why It's Already Unwinding

Mar 18, 2026

LBGJ rockets 138% in pre-market but immediately begins fading from highs, exposing the mechanical nature of the move and underlying dilution risks.

Read →